Table 1.

Intervention received by treatment group

		Best practice advice (n=174)*	Injection and best practice advice (n=178)*	Progressive exercise (n=174)†	Injection and progressive exercise (n=182)†
Injection received		..	168 (94%)	..	171 (94%)
Injection not received		..	10 (6%)	..	11 (6%)
	Did not attend	..	1 (<1%)	..	2 (1%)
	Participant declined	..	4 (2%)	..	4 (2%)
	Clinician declined	..	5 (3%)	..	5 (3%)
Received extra injection		..	0	..	2 (1%)
Completed exercise treatment‡		162 (93%)	162 (91%)	138 (79%)	139 (76%)
Partial exercise completion§		..	..	29 (17%)	33 (18%)
Received no treatment		12 (7%)	16 (9%)	7 (4%)	10 (5%)
	Did not attend or unable to contact	5 (3%)	6 (3%)	3 (2%)	3 (2%)
	Withdrawal or declined	4 (2%)	2 (1%)	1 (<1%)	0
	Other condition	3 (2%)	4 (2%)	0	2 (1%)
	Received wrong trial intervention	0	3 (2%)	2 (1%)	2 (1%)
	Received non-GRASP treatment	0	1 (<1%)	1 (<%)	3 (2%)
Median number of sessions (IQR)		1 (1–1)	1 (1–1)	4 (3–6)	4 (3–5)
Completed session 1		162 (93%)	162 (91%)	167 (96%)	172 (95%)
Completed session 2		..	..	161 (93%)	160 (88%)
Completed session 3		..	..	144 (83%)	136 (75%)
Completed session 4		..	..	101 (58%)	100 (55%)
Completed session 5		..	..	72 (41%)	69 (38%)
Completed session 6		..	..	44 (25%)	38 (21%)
Participants who received additional sessions		3 (2%)	5 (3%)	3 (2%)	2 (1%)
Additional contact sessions¶		4	6	3	5
	Telephone	2	1	0	1
	Face to face	2	5	3	4

Data are n, n (%), or median (IQR). GRASP=Getting it Right: Addressing Shoulder Pain.

^*Maximum one session of best practice advice.

^†Up to six sessions of progressive exercise.

^‡For best practice advice, at least one session attended. For progressive exercise, six sessions attended or discharged by clinician because treatment completed (as marked on treatment log), discharged by clinician following patient-initiated follow-up period with no further contact, or referred on for further investigation or treatment.

^§Defined as at least one session attended.

^¶Some participants received more than one additional contact.